Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

946 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial.
Düngen HD, Kober L, Nodari S, Schou M, Otto C, Becka M, Kanefendt F, Winkelmann BR, Gislason G, Richard F, Nielsen OW, Gheorghiade M, Senni M. Düngen HD, et al. Among authors: gislason g. Clin Pharmacol Drug Dev. 2019 Oct;8(7):942-951. doi: 10.1002/cpdd.633. Epub 2018 Nov 19. Clin Pharmacol Drug Dev. 2019. PMID: 30452784 Clinical Trial.
Statin use after acute myocardial infarction: a nationwide study in Denmark.
Rasmussen JN, Gislason GH, Abildstrom SZ, Rasmussen S, Gustafsson I, Buch P, Friberg J, Køber L, Torp-Pedersen C, Madsen M, Stender S. Rasmussen JN, et al. Br J Clin Pharmacol. 2005 Aug;60(2):150-8. doi: 10.1111/j.1365-2125.2005.02408.x. Br J Clin Pharmacol. 2005. PMID: 16042668 Free PMC article.
Mortality after acute myocardial infarction according to income and education.
Rasmussen JN, Rasmussen S, Gislason GH, Buch P, Abildstrom SZ, Køber L, Osler M, Diderichsen F, Torp-Pedersen C, Madsen M. Rasmussen JN, et al. J Epidemiol Community Health. 2006 Apr;60(4):351-6. doi: 10.1136/jech.200X.040972. J Epidemiol Community Health. 2006. PMID: 16537354 Free PMC article.
Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, Schramm TK, Abildstrom SZ, Køber L, Madsen M, Torp-Pedersen C. Gislason GH, et al. Circulation. 2006 Jun 27;113(25):2906-13. doi: 10.1161/CIRCULATIONAHA.106.616219. Epub 2006 Jun 19. Circulation. 2006. PMID: 16785336 Free article.
946 results